The Asia Pacific Artificial Intelligence In Precision Medicine Market should witness market growth of 33.6% CAGR during the forecast period (2022-2028).
Clinical decision assistance and image analysis are currently AI's most prevalent uses in medical settings. By giving them quick access to information or research that is pertinent to their patient, clinical decision support systems assist physicians in making decisions about treatments, drugs, mental health, and other patient requirements.
AI technologies are being used to analyze CT scans, x-rays, MRIs, and other pictures in the field of medical imaging in order to look for lesions or other findings that a human radiologist would overlook.
Precision medicine, also referred to as 'personalized medicine, ' is a cutting-edge strategy for customizing illness prevention and treatment that considers variations in people's genes, lifestyles, and environments. Targeting the appropriate medications to the appropriate patients at the appropriate times is the aim of precision medicine.
Modern medical technologies and procedures are at the cutting edge in several areas in Japan. Japan is a crucial export market for American pharmaceuticals and the third-largest pharmaceutical market in the world. The healthcare sector has been marketed by the Government of Japan ('GOJ') since 2013 as a key growth driver under the nation's economic revival and growth strategy. The pharmaceutical industry in Japan, along with the healthcare industry, has recently attracted new interest.
The China market dominated the Asia Pacific Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $509.1 Million by 2028.The Japan market is estimated to grow a CAGR of 32.8% during (2022-2028). Additionally, The India market would experience a CAGR of 34.4% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
Clinical decision assistance and image analysis are currently AI's most prevalent uses in medical settings. By giving them quick access to information or research that is pertinent to their patient, clinical decision support systems assist physicians in making decisions about treatments, drugs, mental health, and other patient requirements.
AI technologies are being used to analyze CT scans, x-rays, MRIs, and other pictures in the field of medical imaging in order to look for lesions or other findings that a human radiologist would overlook.
Precision medicine, also referred to as 'personalized medicine, ' is a cutting-edge strategy for customizing illness prevention and treatment that considers variations in people's genes, lifestyles, and environments. Targeting the appropriate medications to the appropriate patients at the appropriate times is the aim of precision medicine.
Modern medical technologies and procedures are at the cutting edge in several areas in Japan. Japan is a crucial export market for American pharmaceuticals and the third-largest pharmaceutical market in the world. The healthcare sector has been marketed by the Government of Japan ('GOJ') since 2013 as a key growth driver under the nation's economic revival and growth strategy. The pharmaceutical industry in Japan, along with the healthcare industry, has recently attracted new interest.
The China market dominated the Asia Pacific Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $509.1 Million by 2028.The Japan market is estimated to grow a CAGR of 32.8% during (2022-2028). Additionally, The India market would experience a CAGR of 34.4% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
Scope of the Study
By Application
- Oncology
- Cardiology
- Neurology
- Respiratory
- Others
By Component
- Software
- Hardware
- Service
By Technology
- Deep Learning
- Natural Language Processing
- Querying Method
- Context Aware Processing
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Artificial Intelligence in precision Medicine Market, by Application
1.4.2 Asia Pacific Artificial Intelligence in precision Medicine Market, by Component
1.4.3 Asia Pacific Artificial Intelligence in precision Medicine Market, by Technology
1.4.4 Asia Pacific Artificial Intelligence in precision Medicine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jan - 2022, Nov) Leading Players
Chapter 4. Asia Pacific Artificial Intelligence in Precision Medicine Market by Application
4.1 Asia Pacific Oncology Market by Country
4.2 Asia Pacific Cardiology Market by Country
4.3 Asia Pacific Neurology Market by Country
4.4 Asia Pacific Respiratory Market by Country
4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Artificial Intelligence in Precision Medicine Market by Component
5.1 Asia Pacific Software Market by Country
5.2 Asia Pacific Hardware Market by Country
5.3 Asia Pacific Service Market by Country
Chapter 6. Asia Pacific Artificial Intelligence in Precision Medicine Market by Technology
6.1 Asia Pacific Deep Learning Market by Country
6.2 Asia Pacific Natural Language Processing Market by Country
6.3 Asia Pacific Querying Method Market by Country
6.4 Asia Pacific Context Aware Processing Market by Country
Chapter 7. Asia Pacific Artificial Intelligence in Precision Medicine Market by Country
7.1 China Artificial Intelligence in Precision Medicine Market
7.1.1 China Artificial Intelligence in Precision Medicine Market by Application
7.1.2 China Artificial Intelligence in Precision Medicine Market by Component
7.1.3 China Artificial Intelligence in Precision Medicine Market by Technology
7.2 Japan Artificial Intelligence in Precision Medicine Market
7.2.1 Japan Artificial Intelligence in Precision Medicine Market by Application
7.2.2 Japan Artificial Intelligence in Precision Medicine Market by Component
7.2.3 Japan Artificial Intelligence in Precision Medicine Market by Technology
7.3 India Artificial Intelligence in Precision Medicine Market
7.3.1 India Artificial Intelligence in Precision Medicine Market by Application
7.3.2 India Artificial Intelligence in Precision Medicine Market by Component
7.3.3 India Artificial Intelligence in Precision Medicine Market by Technology
7.4 South Korea Artificial Intelligence in Precision Medicine Market
7.4.1 South Korea Artificial Intelligence in Precision Medicine Market by Application
7.4.2 South Korea Artificial Intelligence in Precision Medicine Market by Component
7.4.3 South Korea Artificial Intelligence in Precision Medicine Market by Technology
7.5 Singapore Artificial Intelligence in Precision Medicine Market
7.5.1 Singapore Artificial Intelligence in Precision Medicine Market by Application
7.5.2 Singapore Artificial Intelligence in Precision Medicine Market by Component
7.5.3 Singapore Artificial Intelligence in Precision Medicine Market by Technology
7.6 Malaysia Artificial Intelligence in Precision Medicine Market
7.6.1 Malaysia Artificial Intelligence in Precision Medicine Market by Application
7.6.2 Malaysia Artificial Intelligence in Precision Medicine Market by Component
7.6.3 Malaysia Artificial Intelligence in Precision Medicine Market by Technology
7.7 Rest of Asia Pacific Artificial Intelligence in Precision Medicine Market
7.7.1 Rest of Asia Pacific Artificial Intelligence in Precision Medicine Market by Application
7.7.2 Rest of Asia Pacific Artificial Intelligence in Precision Medicine Market by Component
7.7.3 Rest of Asia Pacific Artificial Intelligence in Precision Medicine Market by Technology
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Google LLC (Alphabet Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Intel Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Microsoft Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 IBM Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Tempus, Inc.
8.9.1 Company Overview
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Methodology
LOADING...
